European Archives - Page 208 of 1347 - European Medical Journal

Education or promotion: What wins with HCPs?

When every second of a healthcare professional’s time counts, what content truly earns their attention – disease awareness or product promotion?

EULAR 2025: MRI Detects Early Spinal Changes in axSpA

Presented at EULAR 2025, new 2-year data from the SPACE cohort show that spinal fat lesions on MRI progress in early axial spondyloarthritis, unlike in non-axSpA chronic back pain.

Secondary Bacterial Peritonitis Following a Renal Abscess

Bacterial peritonitis can either arise spontaneously or occur secondary to abscesses or perforations in the abdominal cavity. Both…

Newborn Gut Bacteria Linked to Respiratory Risk in Early Childhood

Early differences in newborn gut microbiota composition may influence risk of hospitalisation for viral lower respiratory tract infections in early childhood.

Diabetes Weight Loss Drugs May Double Risk of Macular Degeneration

GLP-1 RAs may significantly increase the risk of neovascular age-related macular degeneration in older adults with diabetes.

Breakthrough mRNA Delivery Technology Could Reverse HIV Latency

A groundbreaking approach using mRNA-lipid nanoparticle technology has shown the ability to force HIV out of its latent state, offering hope for future curative therapies.

Low-Dose CT Delivers Accurate BMD Results

Understand how ultra-low-dose CT reduces radiation and maintains diagnostic accuracy for osteoporosis, for safer, repeated BMD scans.

Patient-Led Weight Maintenance Outperforms Professional Care in 18-Month Trial

A new patient-led weight maintenance programme outperforms standard care, offering scalable, effective obesity management.

Yacin Marzouki

Yacin Marzouki on disrupting the traditional omnichannel model

Omnichannel engagement expert Yacin Marzouki joins the show to share his strategies on how to make omnichannel work for both pharmaceutical companies and healthcare professionals.

Resistance Persists Years After Azithromycin Mass Drug Administration

Azithromycin mass drug administration may promote durable and transmissible resistance, including in populations not directly exposed.